Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18035193 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Study Comparing Bone Loss in Women Who Take Calcium and Vitamin D With Women Who Also Take Risedronate or Exercise
Condition: Osteopenia.
Interventions: Drug: Calcium carbonate;   Drug: Vitamin D3;   Drug: Risedronate;   Behavioral: Bone-loading exercises
2 Completed Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: risedronate (HMR4003)

Indicates status has not been verified in more than two years